Grass pollen allergy immunotherapy (Leti Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGrass pollen allergy immunotherapy (Leti Pharma)

Drug Alias NameDepigoid 34% GrassesMix/33% olea europaea/33% salsola kali草花粉过敏免疫疗法 - Leti PharmaDepigoid Phleum pratenseDepigoid Grass MixModified allergen extract of Phleum pratense +[6]

ClassificationBiologics > Antigen > Allergen extract

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesLaboratorios Leti Sl

China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Leti Sl

Inactive CompaniesN/A

Active IndicationsConjunctivitis, AllergicRhinitis, Allergic, Seasonal

Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeV01AA02